Your Health, We Care
pemigatinib is an orally active selective inhibitor of fibroblast growth factor receptor (FGFR), with strong inhibitory activity against FGFR1, FGFR2, FGFR3, and FGFR4. Preventing tumor growth and spread by inhibiting FGFR kinase in tumor cells.
Pemigatinib is a targeted drug for cholangiocarcinoma, which has been marketed i···【more】
Release date：2024-08-09Recommended：99
Pemigatinib is a targeted drug that is mainly used to treat cholangiocarcinoma.H···【more】
Release date：2024-08-09Recommended：102
Pemigatinibis a targeted drug for the treatment of cholangiocarcinoma and belong···【more】
Release date：2024-08-09Recommended：113
